Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: Q4Q379
Term | Name | Level | Count |
---|---|---|---|
GO:0000459 | exonucleolytic trimming involved in rRNA processing | 8 | 2 |
GO:0000467 | exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 9 | 2 |
GO:0000469 | cleavage involved in rRNA processing | 7 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006364 | rRNA processing | 8 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016072 | rRNA metabolic process | 7 | 2 |
GO:0031123 | RNA 3'-end processing | 7 | 2 |
GO:0031125 | rRNA 3'-end processing | 9 | 2 |
GO:0034470 | ncRNA processing | 7 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034660 | ncRNA metabolic process | 6 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0043628 | regulatory ncRNA 3'-end processing | 8 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 5 | 2 |
GO:0090501 | RNA phosphodiester bond hydrolysis | 6 | 2 |
GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic | 7 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 9 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0003824 | catalytic activity | 1 | 9 |
GO:0004518 | nuclease activity | 4 | 9 |
GO:0004527 | exonuclease activity | 5 | 9 |
GO:0005488 | binding | 1 | 10 |
GO:0008408 | 3'-5' exonuclease activity | 6 | 9 |
GO:0016787 | hydrolase activity | 2 | 9 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 9 |
GO:0043167 | ion binding | 2 | 8 |
GO:0043169 | cation binding | 3 | 8 |
GO:0046872 | metal ion binding | 4 | 8 |
GO:0097159 | organic cyclic compound binding | 2 | 9 |
GO:1901363 | heterocyclic compound binding | 2 | 9 |
GO:0000175 | 3'-5'-RNA exonuclease activity | 7 | 2 |
GO:0004532 | RNA exonuclease activity | 5 | 2 |
GO:0004540 | RNA nuclease activity | 4 | 2 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 2 |
GO:0016896 | RNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 2 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 2 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 215 | 219 | PF00656 | 0.577 |
CLV_NRD_NRD_1 | 204 | 206 | PF00675 | 0.536 |
CLV_NRD_NRD_1 | 268 | 270 | PF00675 | 0.601 |
CLV_NRD_NRD_1 | 344 | 346 | PF00675 | 0.329 |
CLV_NRD_NRD_1 | 422 | 424 | PF00675 | 0.503 |
CLV_PCSK_KEX2_1 | 204 | 206 | PF00082 | 0.567 |
CLV_PCSK_KEX2_1 | 380 | 382 | PF00082 | 0.420 |
CLV_PCSK_KEX2_1 | 422 | 424 | PF00082 | 0.518 |
CLV_PCSK_KEX2_1 | 492 | 494 | PF00082 | 0.387 |
CLV_PCSK_PC1ET2_1 | 204 | 206 | PF00082 | 0.629 |
CLV_PCSK_PC1ET2_1 | 380 | 382 | PF00082 | 0.436 |
CLV_PCSK_PC1ET2_1 | 492 | 494 | PF00082 | 0.387 |
CLV_PCSK_SKI1_1 | 125 | 129 | PF00082 | 0.306 |
CLV_PCSK_SKI1_1 | 262 | 266 | PF00082 | 0.378 |
CLV_PCSK_SKI1_1 | 269 | 273 | PF00082 | 0.322 |
CLV_PCSK_SKI1_1 | 332 | 336 | PF00082 | 0.385 |
CLV_PCSK_SKI1_1 | 353 | 357 | PF00082 | 0.424 |
CLV_PCSK_SKI1_1 | 407 | 411 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 414 | 418 | PF00082 | 0.428 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.265 |
DOC_CYCLIN_RxL_1 | 401 | 413 | PF00134 | 0.387 |
DOC_MAPK_gen_1 | 269 | 276 | PF00069 | 0.446 |
DOC_MAPK_gen_1 | 471 | 480 | PF00069 | 0.386 |
DOC_MAPK_gen_1 | 77 | 86 | PF00069 | 0.491 |
DOC_MAPK_MEF2A_6 | 269 | 278 | PF00069 | 0.366 |
DOC_MAPK_MEF2A_6 | 281 | 288 | PF00069 | 0.330 |
DOC_MAPK_MEF2A_6 | 471 | 480 | PF00069 | 0.386 |
DOC_PP4_FxxP_1 | 347 | 350 | PF00568 | 0.467 |
DOC_PP4_MxPP_1 | 348 | 351 | PF00568 | 0.387 |
DOC_USP7_MATH_1 | 148 | 152 | PF00917 | 0.431 |
DOC_USP7_MATH_1 | 33 | 37 | PF00917 | 0.505 |
DOC_USP7_MATH_1 | 386 | 390 | PF00917 | 0.481 |
DOC_USP7_UBL2_3 | 110 | 114 | PF12436 | 0.442 |
DOC_USP7_UBL2_3 | 397 | 401 | PF12436 | 0.413 |
DOC_USP7_UBL2_3 | 431 | 435 | PF12436 | 0.443 |
DOC_WW_Pin1_4 | 337 | 342 | PF00397 | 0.428 |
DOC_WW_Pin1_4 | 533 | 538 | PF00397 | 0.622 |
LIG_14-3-3_CanoR_1 | 181 | 188 | PF00244 | 0.421 |
LIG_14-3-3_CanoR_1 | 471 | 477 | PF00244 | 0.439 |
LIG_Actin_WH2_2 | 146 | 163 | PF00022 | 0.490 |
LIG_APCC_ABBA_1 | 371 | 376 | PF00400 | 0.365 |
LIG_APCC_ABBAyCdc20_2 | 435 | 441 | PF00400 | 0.368 |
LIG_BRCT_BRCA1_1 | 35 | 39 | PF00533 | 0.440 |
LIG_BRCT_BRCA1_1 | 435 | 439 | PF00533 | 0.405 |
LIG_BRCT_BRCA1_1 | 95 | 99 | PF00533 | 0.459 |
LIG_FHA_1 | 329 | 335 | PF00498 | 0.415 |
LIG_FHA_1 | 368 | 374 | PF00498 | 0.421 |
LIG_FHA_1 | 473 | 479 | PF00498 | 0.392 |
LIG_FHA_1 | 499 | 505 | PF00498 | 0.315 |
LIG_FHA_2 | 382 | 388 | PF00498 | 0.482 |
LIG_FHA_2 | 435 | 441 | PF00498 | 0.416 |
LIG_IRF3_LxIS_1 | 39 | 44 | PF10401 | 0.477 |
LIG_LIR_Apic_2 | 130 | 135 | PF02991 | 0.505 |
LIG_LIR_Gen_1 | 171 | 179 | PF02991 | 0.296 |
LIG_LIR_Gen_1 | 403 | 412 | PF02991 | 0.362 |
LIG_LIR_Gen_1 | 436 | 446 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 171 | 176 | PF02991 | 0.309 |
LIG_LIR_Nem_3 | 343 | 347 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 357 | 363 | PF02991 | 0.252 |
LIG_LIR_Nem_3 | 403 | 408 | PF02991 | 0.407 |
LIG_LIR_Nem_3 | 436 | 442 | PF02991 | 0.417 |
LIG_PCNA_yPIPBox_3 | 77 | 90 | PF02747 | 0.442 |
LIG_Pex14_2 | 442 | 446 | PF04695 | 0.471 |
LIG_Pex14_2 | 490 | 494 | PF04695 | 0.326 |
LIG_Rb_pABgroove_1 | 272 | 280 | PF01858 | 0.468 |
LIG_REV1ctd_RIR_1 | 43 | 51 | PF16727 | 0.477 |
LIG_SH2_CRK | 289 | 293 | PF00017 | 0.403 |
LIG_SH2_CRK | 405 | 409 | PF00017 | 0.411 |
LIG_SH2_CRK | 95 | 99 | PF00017 | 0.544 |
LIG_SH2_NCK_1 | 383 | 387 | PF00017 | 0.490 |
LIG_SH2_SRC | 360 | 363 | PF00017 | 0.449 |
LIG_SH2_STAP1 | 375 | 379 | PF00017 | 0.389 |
LIG_SH2_STAP1 | 405 | 409 | PF00017 | 0.294 |
LIG_SH2_STAP1 | 95 | 99 | PF00017 | 0.477 |
LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.363 |
LIG_SH2_STAT5 | 251 | 254 | PF00017 | 0.387 |
LIG_SH2_STAT5 | 360 | 363 | PF00017 | 0.440 |
LIG_SH2_STAT5 | 383 | 386 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 497 | 500 | PF00017 | 0.417 |
MOD_CK1_1 | 163 | 169 | PF00069 | 0.554 |
MOD_CK1_1 | 212 | 218 | PF00069 | 0.683 |
MOD_CK2_1 | 127 | 133 | PF00069 | 0.484 |
MOD_CK2_1 | 195 | 201 | PF00069 | 0.551 |
MOD_CK2_1 | 381 | 387 | PF00069 | 0.477 |
MOD_CK2_1 | 434 | 440 | PF00069 | 0.524 |
MOD_CK2_1 | 441 | 447 | PF00069 | 0.368 |
MOD_GlcNHglycan | 167 | 171 | PF01048 | 0.559 |
MOD_GlcNHglycan | 214 | 217 | PF01048 | 0.665 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.616 |
MOD_GlcNHglycan | 244 | 247 | PF01048 | 0.262 |
MOD_GlcNHglycan | 443 | 446 | PF01048 | 0.521 |
MOD_GlcNHglycan | 71 | 74 | PF01048 | 0.242 |
MOD_GlcNHglycan | 95 | 98 | PF01048 | 0.336 |
MOD_GSK3_1 | 317 | 324 | PF00069 | 0.384 |
MOD_GSK3_1 | 506 | 513 | PF00069 | 0.433 |
MOD_GSK3_1 | 69 | 76 | PF00069 | 0.442 |
MOD_N-GLC_1 | 117 | 122 | PF02516 | 0.277 |
MOD_N-GLC_1 | 367 | 372 | PF02516 | 0.327 |
MOD_N-GLC_1 | 82 | 87 | PF02516 | 0.242 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.527 |
MOD_NEK2_1 | 112 | 117 | PF00069 | 0.465 |
MOD_NEK2_1 | 136 | 141 | PF00069 | 0.442 |
MOD_NEK2_1 | 179 | 184 | PF00069 | 0.482 |
MOD_NEK2_1 | 241 | 246 | PF00069 | 0.475 |
MOD_NEK2_1 | 317 | 322 | PF00069 | 0.461 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.475 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.450 |
MOD_NEK2_2 | 367 | 372 | PF00069 | 0.327 |
MOD_NEK2_2 | 400 | 405 | PF00069 | 0.296 |
MOD_NEK2_2 | 434 | 439 | PF00069 | 0.440 |
MOD_PIKK_1 | 317 | 323 | PF00454 | 0.333 |
MOD_PIKK_1 | 381 | 387 | PF00454 | 0.500 |
MOD_PKA_2 | 180 | 186 | PF00069 | 0.468 |
MOD_PKA_2 | 194 | 200 | PF00069 | 0.406 |
MOD_Plk_1 | 117 | 123 | PF00069 | 0.477 |
MOD_Plk_1 | 367 | 373 | PF00069 | 0.335 |
MOD_Plk_1 | 387 | 393 | PF00069 | 0.393 |
MOD_Plk_1 | 73 | 79 | PF00069 | 0.477 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.411 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.487 |
MOD_Plk_4 | 388 | 394 | PF00069 | 0.597 |
MOD_Plk_4 | 400 | 406 | PF00069 | 0.208 |
MOD_Plk_4 | 434 | 440 | PF00069 | 0.485 |
MOD_Plk_4 | 60 | 66 | PF00069 | 0.490 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.505 |
MOD_ProDKin_1 | 337 | 343 | PF00069 | 0.434 |
MOD_SUMO_rev_2 | 183 | 193 | PF00179 | 0.406 |
MOD_SUMO_rev_2 | 273 | 282 | PF00179 | 0.443 |
MOD_SUMO_rev_2 | 389 | 399 | PF00179 | 0.476 |
MOD_SUMO_rev_2 | 482 | 487 | PF00179 | 0.306 |
MOD_SUMO_rev_2 | 500 | 509 | PF00179 | 0.311 |
TRG_DiLeu_BaEn_3 | 387 | 393 | PF01217 | 0.426 |
TRG_DiLeu_BaEn_3 | 424 | 430 | PF01217 | 0.355 |
TRG_DiLeu_BaLyEn_6 | 404 | 409 | PF01217 | 0.372 |
TRG_ENDOCYTIC_2 | 289 | 292 | PF00928 | 0.435 |
TRG_ENDOCYTIC_2 | 360 | 363 | PF00928 | 0.408 |
TRG_ENDOCYTIC_2 | 405 | 408 | PF00928 | 0.338 |
TRG_ENDOCYTIC_2 | 95 | 98 | PF00928 | 0.529 |
TRG_NES_CRM1_1 | 469 | 484 | PF08389 | 0.273 |
TRG_NLS_Bipartite_1 | 191 | 209 | PF00514 | 0.391 |
TRG_NLS_MonoExtN_4 | 204 | 209 | PF00514 | 0.456 |
TRG_Pf-PMV_PEXEL_1 | 407 | 411 | PF00026 | 0.432 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PBV0 | Leptomonas seymouri | 54% | 96% |
A0A0S4IZU9 | Bodo saltans | 31% | 100% |
A0A1X0NK05 | Trypanosomatidae | 26% | 72% |
A0A3S7X7Q1 | Leishmania donovani | 90% | 98% |
A0A422NPF9 | Trypanosoma rangeli | 25% | 68% |
A4HAP1 | Leishmania braziliensis | 73% | 100% |
A4I9T6 | Leishmania infantum | 90% | 98% |
E9B4U7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 98% |
Q8VEG4 | Mus musculus | 25% | 83% |
Q9NVH0 | Homo sapiens | 25% | 87% |